|
Tender for E-Bid For Rate Contract Cum Supply And Empanelment Of Firms For Drugs And Medicines , Fluorouracil Inj Ip 250 Mg/ 5Ml [148] , Mercaptopurine Tablets Ip 50 Mg [152] , Methotrexate Tab Ip 2.5 Mg [154] , Vincristine Injection Ip 1 Mg [159] , Atropine Eye Ointment Ip 1% [319] , Ciprofloxacin Ophthalmic Ointment Usp 0.3% [323] , Dacarbazine Injection 500 Mg Ip [529] , Inj. Ganciclovir Sodium 500Mg (Lyophilized Powder For Reconstitution) [724] , Recombinant F Ix 500 Iu With Diluent [748] , 3Rd Generation Recombinant F Viii 250 Iu With Diluent [749] , Brinozolamide 1% W/V And Brimonidine Tartrate 0.2% W/V Ophthalmic Suspension [Nrd-98] , Gatifloxacin 0.30% And Prednisolone Acetate 1% Ophthalmic Suspension [Nrd-103] , Hpmc 0.3% Eye Drop [Nrd-104] , Proparacaine 0.5% W/V Eye Drop Usp [Nrd-114] , Voriconazole 1 % W/V (Lyophilized) 30Mg Eye Drop [Nrd-119] , Chloramphenicol 1%, Polymyxin B Sulphate (10000 Units) And Dexamethasone 0.1% Sodium Phosphate Eye Ointment [Nrd-123] , Cabazitaxel Injection 60 Mg [Nrd-167] , Carmustine 100 Mg Inj. Ip [Nrd-175] , Fludarabine Phosphate Injection 100Mg Inj. Ip [Nrd-237] , Fludarabine Phosphate Injection 50Mg Inj. Ip [Nrd-238] , Methotrexate 1000 Mg Inj. Ip [Nrd-289] , Inj. Methylprednisolone Acetate 125 Mg I.P. (Each Vial Contains Methylprednisolone Acetate 125 Mg) [Nrd-292] , Mitomycin 40 Mg Inj. Ip [Nrd-297] , Omalizumab 150 Mg Vial Inj. [Nrd-321] , Plerixafor 24 Mg Inj. [Nrd-338] , Rasburicase 1.5 Mg Inj. [Nrd-347] , Recombinant Lh 75Iu Inj. [Nrd-351] , Trabectedin 1 Mg Inj. [Nrd- 387] , Everolimus 5Mg Tab./Cap. [Nrd-530] , Everolimus 10Mg Tab./Cap. [Nrd-531] , Eltrombopag 25Mg Tablet / Capsule [Nrd-617] , Eltrombopag 50Mg Tablet / Capsule [Nrd-618] , Nilotinib 150 Mg Tablet / Capsule [Nrd-710] , Nilotinib 200 Mg Tablet / Capsule [Nrd-711] , Regorafenib 40 Mg Tab. [Nrd-757] , Tegafur 100Mg And Uracil 224Mg Capsule [Nrd-794] , Ulipristal 5Mg Tab. [Nrd-808] Glycopegylated Extended Half Life Factor Viii 1000 Iu
|
